KR880002038B1 - 과불소-치환 화합물을 부형제로서 포함하는 약제 조성물 - Google Patents

과불소-치환 화합물을 부형제로서 포함하는 약제 조성물 Download PDF

Info

Publication number
KR880002038B1
KR880002038B1 KR1019830001426A KR830001426A KR880002038B1 KR 880002038 B1 KR880002038 B1 KR 880002038B1 KR 1019830001426 A KR1019830001426 A KR 1019830001426A KR 830001426 A KR830001426 A KR 830001426A KR 880002038 B1 KR880002038 B1 KR 880002038B1
Authority
KR
South Korea
Prior art keywords
perfluorinated
composition
substituted compound
compound consists
sodium
Prior art date
Application number
KR1019830001426A
Other languages
English (en)
Korean (ko)
Other versions
KR840004366A (ko
Inventor
머레이 요크 쥬니어 빌리이
Original Assignee
앨컨 라보라토리이즈 인코포레이팃드
원본미기재
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 앨컨 라보라토리이즈 인코포레이팃드, 원본미기재 filed Critical 앨컨 라보라토리이즈 인코포레이팃드
Publication of KR840004366A publication Critical patent/KR840004366A/ko
Application granted granted Critical
Publication of KR880002038B1 publication Critical patent/KR880002038B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1019830001426A 1982-04-05 1983-04-06 과불소-치환 화합물을 부형제로서 포함하는 약제 조성물 KR880002038B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36553982A 1982-04-05 1982-04-05
US365,539 1982-04-05

Publications (2)

Publication Number Publication Date
KR840004366A KR840004366A (ko) 1984-10-15
KR880002038B1 true KR880002038B1 (ko) 1988-10-13

Family

ID=23439275

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830001426A KR880002038B1 (ko) 1982-04-05 1983-04-06 과불소-치환 화합물을 부형제로서 포함하는 약제 조성물

Country Status (12)

Country Link
EP (1) EP0091313B1 (US06262066-20010717-C00359.png)
KR (1) KR880002038B1 (US06262066-20010717-C00359.png)
AT (1) ATE56138T1 (US06262066-20010717-C00359.png)
AU (1) AU557980B2 (US06262066-20010717-C00359.png)
CA (1) CA1295948C (US06262066-20010717-C00359.png)
DE (1) DE3381854D1 (US06262066-20010717-C00359.png)
GR (1) GR78151B (US06262066-20010717-C00359.png)
IE (1) IE56412B1 (US06262066-20010717-C00359.png)
IL (1) IL68456A (US06262066-20010717-C00359.png)
NZ (1) NZ203802A (US06262066-20010717-C00359.png)
PT (1) PT76504B (US06262066-20010717-C00359.png)
WO (1) WO1983003544A1 (US06262066-20010717-C00359.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180101640A (ko) * 2012-09-12 2018-09-12 노바리크 게엠베하 부분불소화 알칸 조성물

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3390172T1 (de) * 1982-08-17 1984-11-29 Sun Tech, Inc., Philadelphia, Pa. Perfluorkohlenstoff-Emulsionen, deren Herstellung und deren Verwendung in der Therapie
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US6458376B1 (en) 1990-09-27 2002-10-01 Allergan, Inc. Nonaqueous fluorinated drug delivery suspensions
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US5173298A (en) * 1990-09-27 1992-12-22 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
EP0808636A1 (en) * 1991-11-14 1997-11-26 Alliance Pharmaceutical Corporation Method for partial liquid ventilation using fluorocarbons
US5643601A (en) * 1992-06-26 1997-07-01 Lancaster Group Ag Phospholipid-and fluorocarbon-containing cosmetic
DE4221256C2 (de) * 1992-06-26 1997-07-10 Lancaster Group Ag Galenische Zusammensetzung für die topische Anwendung
DE4221268C2 (de) * 1992-06-26 1997-06-12 Lancaster Group Ag Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
DE69426062T2 (de) * 1993-08-18 2001-03-22 Alcon Lab Inc Zusammensetzungen von ergolinderivaten zur behandlung des glaukoms
WO1995024430A2 (en) 1994-03-04 1995-09-14 University Of Washington Block and graft copolymers and methods relating thereto
US5480914A (en) * 1994-05-06 1996-01-02 Allergan, Inc. Nonaqueous thixotropic drug delivery suspensions and methods of their use
US5874469A (en) * 1996-01-05 1999-02-23 Alcon Laboratories, Inc. Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
DE60043459D1 (de) * 2000-10-13 2010-01-14 Cambridge Biostability Ltd Pharmazeutische flüssige Suspensionen
JP2004513093A (ja) * 2000-10-13 2004-04-30 ケンブリッジ、バイオスタビリティー、リミテッド 安定注射液用の組成物および方法
DE102006040450B3 (de) * 2006-08-24 2008-04-24 Coty Prestige Lancaster Group Gmbh Verwendung einer Zusammensetzung für die Hautbehandlung nach Röntgenbestrahlung

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2968628A (en) * 1958-10-17 1961-01-17 Shulton Inc Propellant composition
US3282781A (en) * 1960-11-25 1966-11-01 Merck & Co Inc Inhalant compositions
NL289785A (US06262066-20010717-C00359.png) * 1962-11-29
US3490923A (en) * 1966-07-28 1970-01-20 Du Pont Aerosol propellant composition used in dispensing foods
US3958014A (en) * 1970-09-05 1976-05-18 The Green Cross Corporation Process for preparing injection-purpose fluorocarbon emulsion capable of carrying oxygen
US3823091A (en) * 1971-05-19 1974-07-09 Green Cross Corp Stable emulsion of fluorocarbon particles
US3929662A (en) * 1973-12-18 1975-12-30 Wave Energy Systems Liquid or gas phase sterilizing and cleaning composition containing an aldehyde and a fluoro or perfluoro compound
US4110474A (en) * 1977-08-26 1978-08-29 Suntech, Inc. Tetramethylpentane blood substitutes
US4187252A (en) * 1977-08-26 1980-02-05 Suntech, Inc. Tetramethylpentane blood substitutes
US4252827A (en) * 1979-05-23 1981-02-24 The Green Cross Corporation Oxygen-transferable fluorocarbon emulsion
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
US4452818A (en) * 1982-03-19 1984-06-05 Haidt Sterling J Extraocular method of treating the eye with liquid perfluorocarbons
JPH08221312A (ja) * 1995-02-14 1996-08-30 Hitachi Ltd メモリカード装置

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180101640A (ko) * 2012-09-12 2018-09-12 노바리크 게엠베하 부분불소화 알칸 조성물

Also Published As

Publication number Publication date
PT76504A (en) 1983-05-01
IE830776L (en) 1983-10-05
EP0091313A2 (en) 1983-10-12
DE3381854D1 (de) 1990-10-11
AU1313883A (en) 1983-10-13
EP0091313A3 (en) 1985-05-22
CA1295948C (en) 1992-02-18
IE56412B1 (en) 1991-07-31
NZ203802A (en) 1985-07-31
IL68456A0 (en) 1983-07-31
KR840004366A (ko) 1984-10-15
GR78151B (US06262066-20010717-C00359.png) 1984-09-26
ATE56138T1 (de) 1990-09-15
IL68456A (en) 1989-09-28
AU557980B2 (en) 1987-01-15
WO1983003544A1 (en) 1983-10-27
EP0091313B1 (en) 1990-09-05
PT76504B (en) 1986-02-27

Similar Documents

Publication Publication Date Title
KR880002038B1 (ko) 과불소-치환 화합물을 부형제로서 포함하는 약제 조성물
AU2009347921B2 (en) Pharmaceutical composition for use in medical and veterinary ophthalmology
ES2461617T3 (es) Composiciones farmacéuticas acuosas que contienen complejos borato-polioles
KR20140077900A (ko) 안정한 포비돈-요오드 조성물
EP0275457B1 (en) Solution containing lysozyme hydrochloride and dipotassium glycyrrhizinate
US6350781B1 (en) Method and analgesic preparations for sustained and extended corneal analgesia with subanesthetic concentrations of lidocaine
WO2013125977A1 (ru) Противовирусные глазные капли
JP3502574B2 (ja) 眼感染症治療用眼軟膏剤
US9187468B2 (en) Topical ocular analgesic agents
US4929619A (en) Anti-infective methods and compositions
JPH0460094B2 (US06262066-20010717-C00359.png)
US4897404A (en) Anti-infective methods and compositions
US3322627A (en) Method of treating herpes simplex infections with 5-methylamino-2'-deoxyuridine, and compositions therefor
RU2812900C2 (ru) Анестезирующая композиция и способ анестезирования глаза
US4895857A (en) Anti-infective methods and compositions
US4895859A (en) Anti-infective methods and compositions
US3609141A (en) Magnesium slat of 5-methyl-3-(2,6-dichlorophenyl)-4-isoxazolyl-penicillin
CA2015427A1 (en) Pharmaceutical composition for topical ophthalmic use having improved local tolerability
EP0375319A3 (en) Angiotensin converting enzyme inhibitors in the treatment of glaucoma
MXPA04002071A (es) Tratamiento de infecciones oculares.
ITMI961557A1 (it) Uso di ipoclorito di sodio per il trattamento di malattie sistemiche e della pelle

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19970930

Year of fee payment: 10

LAPS Lapse due to unpaid annual fee